This talk presents a high-level overview of formulation options for improving small molecule bioavailability, examples of how formulation can make a big impact to oral availability and drug dose, explain when and why they work, choosing a formulation based on molecule properties, and the pros and cons of increasingly adopted technologies like nanoparticle formulation for a small molecule drug discovery audience.

00:00 Sponsor introduction
07:46 Presentation introduction
15:47 Presentation by Tamas Solymosi
49:32 Additional resources
49:50 Q&A

Presented by: Dennis Hu, CEO & Editor-in-Chief, Drug Hunter and Tamas Solymosi Ph.D., Lead Scientist, Nanoform

Thank you to Christian Jones, FRSC, Chief Commercial Officer, Nanoform and Tamas Solymosi Ph.D., Lead Scientist, Nanoform for their support of this webinar.

Presented on December 12, 2023, as part of the Drug Hunter Flash Talk series.

Sign up for future sessions here: [ Ссылка ]

свернуть